Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/117748
Title: Vitamin C and folate status in hereditary fructose intolerance
Authors: Cano, Ainara
Alcalde, Carlos
Belanger-Quintana, Amaya
Cañedo-Villarroya, Elvira
Ceberio, Leticia
Chumillas-Calzada, Silvia
Correcher, Patricia
Couce, María Luz
García-Arenas, Dolores
Gómez, Igor
Hernández, Tomás
Izquierdo-García, Elsa
Martínez Chicano, Dámaris
Morales, Montserrat
Pedrón-Giner, Consuelo
Petrina Jáuregui, Estrella
Peña Quintana, Luis 
Sánchez-Pintos, Paula
Serrano-Nieto, Juliana
Unceta Suarez, María
Vitoria Miñana, Isidro
de las Heras, Javier
UNESCO Clasification: 32 Ciencias médicas
3206 Ciencias de la nutrición
Keywords: Metabolic disorders
Vitamin C
Folate
Fructose
Issue Date: 2022
Journal: European Journal of Clinical Nutrition 
Abstract: Background Hereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients. Methods Vitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls. Results Most of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001). Conclusions Our results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI.
URI: http://hdl.handle.net/10553/117748
ISSN: 1476-5640
DOI: 10.1038/s41430-022-01178-3
Source: European Journal of Clinical Nutrition [1476-5640], (Julio 2022)
Appears in Collections:Artículos
Adobe PDF (630,27 kB)
Show full item record

Page view(s)

78
checked on Feb 17, 2024

Download(s)

12
checked on Feb 17, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.